GT-Bionics lab will participate in the
2005 IEEE Biomedical Circuits and Systems Conference (BioCAS'15) with 6 papers.
BioCAS serves as a premier international forum for presenting the interdisciplinary research and development at the crossroads
of medicine, life sciences, physical sciences and engineering that will shape tomorrow's medical devices and healthcare systems.
Congratulations to Dr. Sarah Ostadabbas for accepting a faculty position at Northeastern University. We at the GT Bionics lab look forward to you making us all proud. We'll miss you!
Dr. Ghovanloo was named an IEEE Circuits and Systems Society Distinguished Lecturer for 2015-2016 term.
The topics on which he will lecture are "Implantable and Wearable Microelectronic Devices to Improve Quality of Life for People with Disabilities"
and "Efficient Power and Wideband Data Transmission in Near Field."
Tongue Drive featured in US NEWS and World Report:
Wearable Tech for People With Disabilities.
Congratulations to Temi for winning the best student paper competition award at the IEEE EMBC'14. All of us here at the GT Bionics lab are proud of you!
GT Bionics participated in the 36th Annual IEEE Engineering in Medicine and Biology Conference in Chicago with 6 papers.
A new story featuring the Tongue Drive System was published in the New Scientist. Please click here for more details.
Congratulations to Dr. Mehdi Kiani for accepting a faculty position at Penn State. We at the GT Bionics lab look forward to you making us all proud. We'll miss you!
Congratulations to Temi for her EMBC'14 paper being selected among the Open Finalists for the student competition. Her paper was titled "Tracheal Activity Recognition Based on Acoustic Signals".
Patients forget to take their medicine, they may think side effects outweigh benefits, they may not believe the diagnosis, they may not understand the directions correctly, they may not know enough about the side-effects, they may use too much, or they may view the medicine as too costly. For whatever reason, even the best medications cannot cure diseases if the patients do not take them in the right doses at the right time. The topic of “pharmaceutical compliance” has become a key issue due to increasing difficulties in achieving point-of-differentiation and health economic objectives justifying premium pricing and reimbursement. We are working on a novel drug compliance monitoring device suitable for clinical and pharmaceutical trials. It can also be an integrated part of the marketed drug concepts.